These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11220743)
1. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Johnston JB; Zhang K; Silva C; Shalinsky DR; Conant K; Ni W; Corbett D; Yong VW; Power C Ann Neurol; 2001 Feb; 49(2):230-41. PubMed ID: 11220743 [TBL] [Abstract][Full Text] [Related]
2. Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism. Rumbaugh J; Turchan-Cholewo J; Galey D; St Hillaire C; Anderson C; Conant K; Nath A FASEB J; 2006 Aug; 20(10):1736-8. PubMed ID: 16807369 [TBL] [Abstract][Full Text] [Related]
3. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. Noorbakhsh F; Vergnolle N; McArthur JC; Silva C; Vodjgani M; Andrade-Gordon P; Hollenberg MD; Power C J Immunol; 2005 Jun; 174(11):7320-9. PubMed ID: 15905579 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. Pérez A; Probert AW; Wang KK; Sharmeen L J Neurovirol; 2001 Feb; 7(1):1-10. PubMed ID: 11519477 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Buscemi L; Ramonet D; Geiger JD Neurobiol Dis; 2007 Jun; 26(3):661-70. PubMed ID: 17451964 [TBL] [Abstract][Full Text] [Related]
6. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933 [TBL] [Abstract][Full Text] [Related]
7. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986 [TBL] [Abstract][Full Text] [Related]
8. Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. Haughey NJ; Holden CP; Nath A; Geiger JD J Neurochem; 1999 Oct; 73(4):1363-74. PubMed ID: 10501179 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Sui Z; Sniderhan LF; Fan S; Kazmierczak K; Reisinger E; Kovács AD; Potash MJ; Dewhurst S; Gelbard HA; Maggirwar SB Eur J Neurosci; 2006 May; 23(10):2623-34. PubMed ID: 16817865 [TBL] [Abstract][Full Text] [Related]
10. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes. Pocernich CB; Sultana R; Hone E; Turchan J; Martins RN; Calabrese V; Nath A; Butterfield DA J Neurosci Res; 2004 Aug; 77(4):532-9. PubMed ID: 15264223 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. Conant K; St Hillaire C; Anderson C; Galey D; Wang J; Nath A J Neurovirol; 2004 Feb; 10(1):21-8. PubMed ID: 14982725 [TBL] [Abstract][Full Text] [Related]
12. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Gurwell JA; Nath A; Sun Q; Zhang J; Martin KM; Chen Y; Hauser KF Neuroscience; 2001; 102(3):555-63. PubMed ID: 11226693 [TBL] [Abstract][Full Text] [Related]
14. A soluble factor produced by macrophages mediates the neurotoxic effects of HIV-1 Tat in vitro. Brana C; Biggs TE; Barton CH; Sundstrom LE; Mann DA AIDS; 1999 Aug; 13(12):1443-52. PubMed ID: 10465066 [TBL] [Abstract][Full Text] [Related]
15. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. Shi B; Raina J; Lorenzo A; Busciglio J; Gabuzda D J Neurovirol; 1998 Jun; 4(3):281-90. PubMed ID: 9639071 [TBL] [Abstract][Full Text] [Related]
16. The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Self RL; Mulholland PJ; Nath A; Harris BR; Prendergast MA Brain Res; 2004 Jan; 995(1):39-45. PubMed ID: 14644469 [TBL] [Abstract][Full Text] [Related]
17. Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Ju SM; Song HY; Lee JA; Lee SJ; Choi SY; Park J Exp Mol Med; 2009 Feb; 41(2):86-93. PubMed ID: 19287189 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Silva C; Zhang K; Tsutsui S; Holden JK; Gill MJ; Power C Ann Neurol; 2003 Nov; 54(5):605-14. PubMed ID: 14595650 [TBL] [Abstract][Full Text] [Related]
19. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650 [TBL] [Abstract][Full Text] [Related]
20. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Toschi E; Barillari G; Sgadari C; Bacigalupo I; Cereseto A; Carlei D; Palladino C; Zietz C; Leone P; Stürzl M; Buttò S; Cafaro A; Monini P; Ensoli B Mol Biol Cell; 2001 Oct; 12(10):2934-46. PubMed ID: 11598182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]